222 related articles for article (PubMed ID: 23029458)
1. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.
Luo YL; Ye P; Zhang QH; Hu TT; Luo MH; Li MQ; Chen Q
PLoS One; 2012; 7(9):e46272. PubMed ID: 23029458
[TBL] [Abstract][Full Text] [Related]
2. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
3. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.
Wu CY; Yang M; Lin M; Li LP; Wen XZ
Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325
[TBL] [Abstract][Full Text] [Related]
4. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
Yu L; Chang K; Han J; Deng S; Chen M
PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.
Silva NNT; Sabino AP; Tafuri A; Lima AA
BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the Caucasian and Asian.
Gao M; Feng N; Zhang M; Ti X; Zuo X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32614041
[TBL] [Abstract][Full Text] [Related]
7. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
8. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
[TBL] [Abstract][Full Text] [Related]
9. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.
Tang M; Wang SQ; Liu BJ; Cao Q; Li BJ; Li PC; Li YF; Qin C; Zhang W
Mol Biol Rep; 2014 Jul; 41(7):4659-73. PubMed ID: 24744129
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis.
Wu H; Zhu P; Geng X; Liu Z; Cui L; Gao Z; Jiang B; Yang L
Arch Gynecol Obstet; 2017 May; 295(5):1105-1118. PubMed ID: 28283826
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.
Xu XJ; Zou LW; Wang DB
Mol Biol Rep; 2013 Jan; 40(1):255-62. PubMed ID: 23070908
[TBL] [Abstract][Full Text] [Related]
12. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
14. Association of the MTHFR C677T polymorphism with primary brain tumor risk.
Xu C; Yuan L; Tian H; Cao H; Chen S
Tumour Biol; 2013 Dec; 34(6):3457-64. PubMed ID: 23846816
[TBL] [Abstract][Full Text] [Related]
15. Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies.
Wu YL; Ding XX; Sun YH; Yang HY; Chen J; Zhao X; Jiang YH; Lv XL; Wu ZQ
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():78-85. PubMed ID: 23831680
[TBL] [Abstract][Full Text] [Related]
16. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
Fu LY; Dai LM; Li XG; Zhang K; Bai Y
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():56-61. PubMed ID: 24192663
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
[TBL] [Abstract][Full Text] [Related]
18. Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.
Cao Y; Xu J; Zhang Z; Huang X; Zhang A; Wang J; Zheng Q; Fu L; Du J
Gene; 2013 Feb; 514(2):105-11. PubMed ID: 23201418
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis.
Guo LN
Asian Pac J Cancer Prev; 2012; 13(5):2193-7. PubMed ID: 22901193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
